Reports
Sale
North America In-Vitro Diagnostics Market Size, Forecast: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology: Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others; By Application; Regional Analysis; Competitive Landscape; 2024-2032
North America In-vitro Diagnostics Market Outlook
The North America in-vitro diagnostics market is expected to grow at a CAGR of 4.7% during the period 2024-2032. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Generally, in-vitro diagnostics (IVD) tests are considered medical gadgets. These may include reagents, techniques, instruments, or a combination thereof employed in-vitro for the investigation of samples such as blood, urine or tissue to obtain a diagnosis from assays in a controlled environment outside a living organism. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Likely to be Driven by Demand for Quality Medical Care and Advanced Solutions by Leading Companies
A majority of in-vitro diagnostics market is concentrated in developed nations, key being USA, Europe and Japan; the in-vitro diagnostics market, overall, is led by major players including Roche Diagnostics, Abbott Diagnostics, Siemens, Johnson & Johnson Medical Devices and Diagnostics, Beckman Coulter and BioMerieux. Roche Diagnostics is a key player in in-vitro diagnostics and tissue-based cancer diagnostics. In 2020, 23 billion tests were carried out across the world using the company’s diagnostics products. Companies like Roche are engaged in understanding how diseases differ at the molecular level, and developing novel tests and drugs that prevent, diagnose and treat such illnesses. Diagnosis is an important and complex activity; accurate diagnosis is vital to ensure correct treatment. Roche Diagnostics Canada offers a distinct and wide product portfolio, with advanced solutions to physicians, hospitals, laboratories, patients, and researchers, in the domains of immunology, clinical chemistry, molecular biology, point-of-care, pathology and life science.
Point of Care Diagnostics Expected to Boost Market Growth
The domain of point-of-care (POC) diagnostics offers the likelihood of providing rapid diagnostic results in non-laboratory environments. With increasingly connected consumer electronic devices, patients and consumers are progressively changing their interaction with POC medical technologies in conjunction with mobile devices; consumers are looking to manage and take control of their own health. POC diagnostic and monitoring devices are likely to increase in popularity in various environments, including home, hospital, clinic, and in developed as well as developing nations. Point of care (POC) diagnostics comprises a significant portion of the total in-vitro diagnostics market in the USA, with the US dominating the general POC market; rising popularity of POC diagnostics is expected to stimulate the growth of the North America in-vitro diagnostics market.
Expansion of Capabilities by Major Companies Likely to Stimulate the Market
Major companies are looking to broaden their offerings and come together to enhance capabilities. For example, in 2023, Medix Biochemica acquired all shares of Bioresrouce Technology to widen its base matrix abilities and further reinforce its local presence in the United States market. Through the partnership, Medix Biochemica would provide its customers an extensive offering of raw materials for IVD quality control products. The organisation and operations of BRT would form a significant portion of Medix Biochemica’s IVD Biomaterials Business Unit, which also comprised manufacturing of native antigens, enzymes, proteins and biologicals in St. Louis, Missouri. Such developments are likely to boost the North America in-vitro diagnostics market.
In 2023, ALine, Inc. and Nectar Product Development announced a strategic partnership to advance point-of-care IVD medical products. The partnership sought to get the microfluidic consumable design to interface robustly with the instrument while fulfilling all instrument design and performance requirements.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
By product and service, the market is segmented into:
- Reagents and Kits
- Instruments
- Software and Services
By technology, the market is divided into:
- Immunoassay/Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Haematology
- Blood Glucose Self-Monitoring
- Coagulation and Haemostasis
- Urinalysis
- Others
By application, the market is divided into:
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Autoimmune Diseases
- Nephrology
- Others
By country, the market is classified into:
- United States
- Canada
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the North America in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Surmodics IVD, Inc.
- Illumina, Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Service |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 North America
7 Opportunities and Challenges in the Market
8 North America In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 North America In-Vitro Diagnostics Historical Market (2018-2023)
8.3 North America In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 North America In-Vitro Diagnostics Market by Product and Service
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 North America In-Vitro Diagnostics Market by Technology
8.5.1 Immunoassay/Immunochemistry
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Clinical Chemistry
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Molecular Diagnostics
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Microbiology
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Haematology
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Blood Glucose Self-Monitoring
8.5.6.1 Historical Trend (2018-2023)
8.5.6.2 Forecast Trend (2024-2032)
8.5.7 Coagulation and Haemostasis
8.5.7.1 Historical Trend (2018-2023)
8.5.7.2 Forecast Trend (2024-2032)
8.5.8 Urinalysis
8.5.8.1 Historical Trend (2018-2023)
8.5.8.2 Forecast Trend (2024-2032)
8.5.9 Others
8.6 North America In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Oncology
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Cardiology
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Autoimmune Diseases
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 Nephrology
8.6.6.1 Historical Trend (2018-2023)
8.6.6.2 Forecast Trend (2024-2032)
8.6.7 Others
8.7 North America In-Vitro Diagnostics Market by Country
8.7.1 United States
8.7.2 Canada
9 Regional Analysis
9.1 United States
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Becton, Dickinson and Company
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Beckman Coulter, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Surmodics IVD, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Illumina, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. North America In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. North America In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2018-2023
3. North America In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. North America In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5. North America In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. North America In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2018-2023
7. North America In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. North America In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
9. North America In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. North America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. North America In-Vitro Diagnostics Market Structure.
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 4.7% between 2024 and 2032.
The major drivers of the North America in-vitro diagnostics market include the technological advancements, rising levels of income, rising standards of living, newly insured patients, and modernised healthcare facilities.
The rising popularity of point of care diagnostics and growing demand for quality medical care are the key industry trends propelling the market's growth.
The major countries in the industry are United States and Canada.
The various products and services in the market are reagents and kits, instruments, software and services.
Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, haematology, blood glucose self-monitoring, coagulation and haemostasis, and urinalysis, among others.
The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.
The major players in the industry are Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Surmodics IVD, Inc., and Illumina, Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER